Search

Learn about the Conrad Lab's research

Skip to main content Effectiveness of Ultrasound and AFP for HCC Screening Ultrasound and alpha-fetoprotein (AFP) have long been cornerstones of hepatocellular carcinoma (HCC) screening in patients with cirrhosis. We have explored how ultrasound quality, operator variability, and patient characterist…

The Bann Laboratory focuses on discovering novel mechanistic targets to treat heart failure. We aim to identify regulators of cardiac cell fate reprogramming and regeneration as a molecular strategy to repair and heal the heart following injury.

Join Gao Lab

Skip to main content Emerging Imaging Strategies for HCC Screening Advances in imaging also offer promising alternatives for HCC screening. For example, abbreviated MRI protocols maintain diagnostic accuracy while reducing patient burden and resource use; however, its use must be considered in the co…

Gao Lab news

Skip to main content Cost Effectiveness of HCC screening We have conducted cost-effectiveness studies showing that screening is cost-effective compared to no screening. We have also shown that biomarker-based screening would be cost-effective, depending on utilization, costs of tests, and sensitivity…

Skip to main content Emerging Blood-based Biomarkers for HCC Screening Blood-based biomarkers offer a non-invasive, scalable strategy for HCC screening that can increase sensitivity for early-stage HCC as well as adherence. Tests like GALAD and methylated DNA panels have shown promise in improving se…

Read about IOTN i3 Center

Contact Gao Lab